ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,510.73
-1.00%
S&P 500
6,032.38
0.56%
Dow Jones
44,910.65
0.42%
US Dollar vs Yen
149.765
0.01%
Brent Oil
71.98
-0.08%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Alexion Pharmaceuticals Inc (ALXN)

  7. Alexion Pharmaceuticals Inc (ALXN) ニュース

ALXN

Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ALXN
日付受信時刻ニュースソース見出しコード企業名
2023/07/2817 : 54KR Market News알렉시온, 화이자 유전자 치료제를 10억 달러 인수 합의NASDAQ:ALXNAlexion Pharmaceuticals Inc
2023/07/2817 : 23KR Market News아스트라제네카, 항암제 수요로 2분기 결과 예상치 상회NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2619 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2619 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2619 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2619 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2619 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2405 : 36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2222 : 09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 23Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
2021/07/2219 : 21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ALXN

最近閲覧した銘柄

NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US30
US 30
NYSE
MRK
Merck
NYSE
NKE
Nike
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
AMEX
XLF
Financial Select Sector
NASDAQ
NVDA
NVIDIA
CCOM
SILVER
SILVER
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有

BLACK FRIDAY

ADVFN

25周年を記念 1999-2024

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

*3年間で¥ 153396、たったの¥ 61358